magAssist gets approval for International Science & Technology Collaboration Project of Jiangsu Province

magAssist's key technology R&D Project-Short and Medium-Term Extracorporeal Ventricular Assist Device-has recently gained approval in the 2018 Jiangsu Province Policy Guidance Program (International Science and Technology Cooperation) List.

Extracorporeal Ventricular Assist Device (Extra-VAD) serve as a lifesaving emergency treatment to maintain blood circulation and body functions of patients with cardiac failures in various acute scenarios. An artificial heart could be removed after returning failing hearts to their normal function after a period of rest or after transitioning to other treatments.

One of the technical challenges of artificial hearts is hemocompatibility. Improvement of hemocompatibility is conducive to provide longer and safer circulatory support, enhance survival rate and reduce surgical complications and the irreversible damages on patients'heart and organs. Partnering with the world-leading computational fluid mechanics research teams from RWTH Aachen University in Germany, magAssist will leverage computational fluid dynamics technology to optimize its hemocompatibility design, carry out research and development of the drive and control system and performance optimization, and verify its production techniques. The company will make breakthroughs in the short and medium-term extracorporeal artificial heart and develop China's first ever extra-VAD. In addition, through international cooperation, magAssist will establish an internationally advanced R&D platform on artificial organs and high-end medical device.

RWTH Aachen University is hailed as the MIT in Europe. Its Department of Cardiovascular Engineering has made great contributions to the development of artificial hearts in the world. It has created the prototypes of the world-renowned minimally invasive artificial heart Impella and device Circulite and has leveraged its computational fluid dynamics technology to support the R&D of extracorporeal blood pumps of famous corporations like Fresenius and Sorin.